Suppr超能文献

间歇性和慢性腹膜透析期间西咪替丁的清除率

Cimetidine clearance during intermittent and chronic peritoneal dialysis.

作者信息

Hyneck M L, Murphy J F, Lipschutz D E

出版信息

Am J Hosp Pharm. 1981 Nov;38(11):1760-2.

PMID:7304634
Abstract

A case report evaluating the clearance of cimetidine during intermittent peritoneal dialysis and chronic ambulatory peritoneal dialysis is presented. A 50-year-old white man with end-stage renal disease using chronic ambulatory peritoneal dialysis was hospitalized with uremic pericarditis. He was treated with indomethacin and aggressive intermittent peritoneal dialysis. Cimetidine 300 mg every 12 hours was prescribed for ulcer prophylaxis. After taking cimetidine for seven days, the clearance of cimetidine during intermittent peritoneal dialysis was evaluated by collecting blood and dialysate samples during a four-hour dialysis period. The patient was discharged using chronic ambulatory peritoneal dialysis. Cimetidine 300 mg every 12 hours was continued. One week after discharge, the clearance of cimetidine during a four-hour dwell period of chronic ambulatory peritoneal dialysis was measured. Cimetidine clearance was approximately 4 ml/min for both intermittent and chronic ambulatory peritoneal dialysis. Clinically unimportant quantities of cimetidine were removed by intermittent and chronic ambulatory peritoneal dialysis. The need for supplemental doses of cimetidine during peritoneal dialysis is not supported.

摘要

本文呈现了一份病例报告,评估了西咪替丁在间歇性腹膜透析和持续性非卧床腹膜透析期间的清除情况。一名50岁的白人男性,患有终末期肾病,采用持续性非卧床腹膜透析,因尿毒症性心包炎住院。他接受了吲哚美辛治疗和积极的间歇性腹膜透析。为预防溃疡,每12小时服用300毫克西咪替丁。服用西咪替丁七天后,通过在四小时透析期间采集血液和透析液样本,评估了间歇性腹膜透析期间西咪替丁的清除情况。患者出院后继续采用持续性非卧床腹膜透析,每12小时服用300毫克西咪替丁。出院一周后,测量了持续性非卧床腹膜透析四小时驻留期内西咪替丁的清除情况。间歇性和持续性非卧床腹膜透析的西咪替丁清除率均约为4毫升/分钟。间歇性和持续性非卧床腹膜透析清除的西咪替丁量在临床上无重要意义。腹膜透析期间不支持额外补充西咪替丁剂量。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验